Familial Atherosclerosis Treatment Study

PHASE3CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

January 31, 1984

Primary Completion Date

August 31, 1989

Study Completion Date

August 31, 1989

Conditions
Cardiovascular DiseasesCoronary ArteriosclerosisCoronary DiseaseHeart DiseasesMyocardial Ischemia
Interventions
DRUG

lovastatin

Lovastatin was begun at a dose of 20 mg twice a day (in the morning and at bedtime). If the LDL cholesterol level did not fall below 3.1 mmol per liter after three months, the dose of lovastatin was increased to 40 mg twice a day.

DRUG

colestipol

Colestipol was begun at a dose of 5 g three times a day with meals and increased to 10 g three times a day after 10 days, unless side effects delayed the increase. Psyllium hydrophic mucilloid (Metamucil) was provided if dietary bran was insufficient to control constipation.

DRUG

niacin

Niacin was started at 125 mg twice a day and gradually increased to 500 mg four times a day (with meals and at bedtime) at one month and 1 g four times a day at two months. If the LDL cholesterol level did not fall below 3.1 mmol per liter (120 mg per deciliter) after three months, the dose of niacin was increased to 1.5 g (three tablets) four times a day, but no further.

OTHER

Placebo for colestipol

Placebo for colestipol.

OTHER

Placebo for lovastatin

Placebo for lovastatin

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Washington

OTHER